Message #1 From:
NewsBot Date: October 6, 2005 01:00:00 AM
EVSD News Endothil Featured in New Print Ad Campaign
MONTGOMERY, Texas--(BUSINESS WIRE)--Oct. 6, 2005--Endovasc, Inc - (OTCBB: EVSC) (OTC:EVSD) announces a nationwide print ad campaign to promote Endothil-CR, a non-steroid supplement based on a proprietary technology for muscle cell recruiting and accelerated body building. Advertisements for Endothil will appear in "Maxim", "Men's Health", and "Muscle & Fitness" magazines, three of the top men's magazines in the US. Maxim is the most popular Men's magazine with a circulation of over 2.5 million in the US, in addition to boasting a large international presence. Men's Health has approximately 1.7 million readers each month and Muscle and Fitness Magazine has a monthly circulation of over 500,000 readers.
In July 2003, Endovasc finalized a product licensing agreement with Western Holdings, a company affiliated with Basic Research. Endothil-CR was launched in March of 2005 at the Arnold Classic International Fitness Weekend held in Columbus, Ohio. The product is currently being distributed throughout GNC stores nationwide and consumers can order by phone or online at the website, www.endothil.com.
Endovasc's wholly-owned subsidiary, Nutraceutical Development Corporation (NDC) was established to create a nutraceutical pipeline. Endovasc's first formulation contains a naturally occurring plant alkaloid as the primary active component. The intended outcome is enhanced muscle mass and reduction of body fat.
The foregoing statements are made under the "Safe Harbor" Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements that involve risks and uncertainties that may not be evident at the time of this release. For more information about Endovasc, please visit www.endovasc.com.
